AU5311800A - Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits - Google Patents
Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid depositsInfo
- Publication number
- AU5311800A AU5311800A AU53118/00A AU5311800A AU5311800A AU 5311800 A AU5311800 A AU 5311800A AU 53118/00 A AU53118/00 A AU 53118/00A AU 5311800 A AU5311800 A AU 5311800A AU 5311800 A AU5311800 A AU 5311800A
- Authority
- AU
- Australia
- Prior art keywords
- protein aggregation
- imaging
- inhibiting
- rhodanine derivatives
- amyloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13854499P | 1999-06-10 | 1999-06-10 | |
US60138544 | 1999-06-10 | ||
PCT/US2000/015069 WO2000076987A1 (en) | 1999-06-10 | 2000-05-31 | Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5311800A true AU5311800A (en) | 2001-01-02 |
Family
ID=22482512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53118/00A Abandoned AU5311800A (en) | 1999-06-10 | 2000-05-31 | Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1192143A1 (pt) |
JP (1) | JP2003502320A (pt) |
AU (1) | AU5311800A (pt) |
BR (1) | BR0011441A (pt) |
CA (1) | CA2374616A1 (pt) |
MX (1) | MXPA01010490A (pt) |
TR (1) | TR200103562T2 (pt) |
WO (1) | WO2000076987A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20020394A1 (es) | 2000-08-18 | 2002-06-21 | Agouron Pharma | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 |
AU2003280188A1 (en) | 2002-12-06 | 2004-06-30 | Warner-Lambert Company Llc | Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
US20060106077A1 (en) * | 2003-07-18 | 2006-05-18 | Pintex Pharmaceuticals, Inc. | Pin1-Modulating compounds and methods of use thereof |
JP2010518064A (ja) | 2007-02-12 | 2010-05-27 | メルク・シャープ・エンド・ドーム・コーポレイション | Adおよび関連状態の治療のためのピペラジン誘導体 |
US8933075B2 (en) | 2010-06-17 | 2015-01-13 | Fuzians Biomedicals, Inc. | Compounds useful as antiviral agents, compositions, and methods of use |
CN106045986B (zh) * | 2016-05-31 | 2019-12-06 | 广东工业大学 | 一种新型吩噻嗪衍生物及其制备方法与应用 |
CN106045987B (zh) * | 2016-06-21 | 2019-04-23 | 广东工业大学 | 一种具有多功能近红外荧光磁性纳米微粒及其制备和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5740478A (en) * | 1980-08-22 | 1982-03-06 | Ono Pharmaceut Co Ltd | Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative |
JPH01147476A (ja) * | 1987-12-03 | 1989-06-09 | Mita Ind Co Ltd | 光導電性トナー |
JPH01147462A (ja) * | 1987-12-03 | 1989-06-09 | Mita Ind Co Ltd | 電荷発生材料およびその製法 |
US5143929A (en) * | 1991-05-09 | 1992-09-01 | Warner-Lambert Company | 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents |
EP0915090A1 (en) * | 1992-09-10 | 1999-05-12 | Eli Lilly And Company | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
DE4318550A1 (de) * | 1993-06-04 | 1994-12-08 | Boehringer Mannheim Gmbh | Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6251928B1 (en) * | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
AU1529297A (en) * | 1996-01-24 | 1997-08-20 | Warner-Lambert Company | Method of imaging amyloid deposits |
EP1128832A4 (en) * | 1998-08-21 | 2003-03-05 | Viropharma Inc | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES |
EP1117655A1 (en) * | 1998-09-30 | 2001-07-25 | Angelika Esswein | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
-
2000
- 2000-05-31 TR TR2001/03562T patent/TR200103562T2/xx unknown
- 2000-05-31 CA CA002374616A patent/CA2374616A1/en not_active Abandoned
- 2000-05-31 BR BR0011441-3A patent/BR0011441A/pt not_active IP Right Cessation
- 2000-05-31 EP EP00938021A patent/EP1192143A1/en not_active Withdrawn
- 2000-05-31 AU AU53118/00A patent/AU5311800A/en not_active Abandoned
- 2000-05-31 WO PCT/US2000/015069 patent/WO2000076987A1/en not_active Application Discontinuation
- 2000-05-31 MX MXPA01010490A patent/MXPA01010490A/es unknown
- 2000-05-31 JP JP2001503845A patent/JP2003502320A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1192143A1 (en) | 2002-04-03 |
TR200103562T2 (tr) | 2002-04-22 |
MXPA01010490A (es) | 2005-05-27 |
JP2003502320A (ja) | 2003-01-21 |
WO2000076987A1 (en) | 2000-12-21 |
BR0011441A (pt) | 2002-07-16 |
CA2374616A1 (en) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2002002389A0 (en) | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives | |
IL146634A0 (en) | Thiazole and oxazole derivatives and their pharmaceutical use | |
AU1432999A (en) | Mr imaging method and medical device for use in method | |
AU2002211517A1 (en) | Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits | |
AU2044400A (en) | Method and apparatus for removing and disposing of body fluids | |
AU8002700A (en) | Method and apparatus for the early detection of tissue pathology using wavelet transformation | |
PL349132A1 (en) | Method and kit for extracting prion protein | |
IL145942A0 (en) | Method and apparatus for measuring cardiac flow output | |
IL146971A0 (en) | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits | |
AU2254501A (en) | Apparatus and method for denture cleaning storage | |
AU7847400A (en) | Method for determining and modifying protein/peptide solubility | |
AU6044300A (en) | Method and arrangement for measuring characteristics of a non-newtonian fluid | |
AU5311800A (en) | Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits | |
IL136629A0 (en) | Methods and apparatus for permitting transaction across firewalls | |
AU2001248820A1 (en) | Thiazole and oxazole derivatives | |
AU2421801A (en) | Shim removing tool and method | |
EP1172655A4 (en) | MEGSIN PROTEIN DETECTION METHOD AND USE THEREOF | |
AU4384400A (en) | Method and device for determining the color of teeth | |
AU6153200A (en) | Use of creatine and/or creatine derivatives for treating feelings of ill-health in women | |
AU5438801A (en) | Method and device for cleaning areas of the pharynx | |
AU3827700A (en) | Method and apparatus for creating artificial reflection | |
AU6979800A (en) | Device and method for the partial electrochemical treatment of bar-shaped elements | |
AU1469701A (en) | Apparatus and method for disease detection | |
SI1189895T1 (sl) | Tiazolni in oksazolni derivati in njihova farmacevtska uporaba | |
AU3169400A (en) | Method and device for moulding titanium parts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |